The device company also reported a 2.9 percent increase in net sales to $2.11 billion, up 2.7 percent from the previous year. Sales related to their neurology and spine business lines saw the greatest growth, increasing 12 percent from the previous year.
More Articles on Stryker:
Stryker Recalls Two Metal Hip Implants
43 Orthopedic & Spine Devices Receive FDA Clearance in May
10 Spine Device Company Executive Moves
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
